Quantitative analysis of mutated EGFR transcripts for assessment of gefitinib sensitivity of non-small-cell lung cancer.

被引：0
|
作者：
Taniguchi, K
Koizumi, K
Orita, N
Sugimoto, Y
Okami, J
Higashiyama, M
Kodama, K
Kato, K
机构：
[1] Osaka Med Ctr Canc & Cardiovasc Dis, Inst Res, Osaka, Japan
[2] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Thorac Surg, Osaka, Japan
来源：
CLINICAL CANCER RESEARCH | 2005年 / 11卷 / 24期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：9049S / 9049S
页数：1
相关论文
共 50 条
  • [1] Gefitinib or Chemotherapy for Non-Small-Cell Lung Cancer with Mutated EGFR.
    Maemondo, Makoto
    Inoue, Akira
    Kobayashi, Kunihiko
    Sugawara, Shunichi
    Oizumi, Satoshi
    Isobe, Hiroshi
    Gemma, Akihiko
    Harada, Masao
    Yoshizawa, Hirohisa
    Kinoshita, Ichiro
    Fujita, Yuka
    Okinaga, Shoji
    Hirano, Haruto
    Yoshimori, Kozo
    Harada, Toshiyuki
    Ogura, Takashi
    Ando, Masahiro
    Miyazawa, Hitoshi
    Tanaka, Tomoaki
    Saijo, Yasuo
    Hagiwara, Koichi
    Morita, Satoshi
    Nukiwa, Toshihiro
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (25): : 2380 - 2388
  • [2] Icotinib is as efficacious as gefitinib for brain metastasis of EGFR mutated non-small-cell lung cancer
    Kejun Liu
    Guanming Jiang
    Ailing Zhang
    Zhuanghua Li
    Jun Jia
    [J]. BMC Cancer, 20
  • [3] Icotinib is as efficacious as gefitinib for brain metastasis of EGFR mutated non-small-cell lung cancer
    Liu, Kejun
    Jiang, Guanming
    Zhang, Ailing
    Li, Zhuanghua
    Jia, Jun
    [J]. BMC CANCER, 2020, 20 (01)
  • [4] Cost-effectiveness analysis of afatinib vs gefitinib in EGFR-mutated population with advanced non-small-cell lung cancer.
    Chouaid, Christos
    Luciani, Laura
    Le Lay, Kate
    De Pouvourville, Gerard
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [5] EGFR mutation and resistance of non-small-cell lung cancer to gefitinib
    Kobayashi, S
    Boggon, TJ
    Dayaram, T
    Janne, PA
    Kocher, O
    Meyerson, M
    Johnson, BE
    Eck, MJ
    Tenen, DG
    Halmos, B
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (08): : 786 - 792
  • [6] Rociletinib in EGFR-Mutated Non-Small-Cell Lung Cancer
    He, Yong
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (06): : 578 - 578
  • [7] Rociletinib in EGFR-Mutated Non-Small-Cell Lung Cancer
    Sequist, L. V.
    Soria, J-C
    Goldman, J. W.
    Wakelee, H. A.
    Gadgeel, S. M.
    Varga, A.
    Papadimitrakopoulou, V.
    Solomon, B. J.
    Oxnard, G. R.
    Dziadziuszko, R.
    Aisner, D. L.
    Doebele, R. C.
    Galasso, C.
    Garon, E. B.
    Heist, R. S.
    Logan, J.
    Neal, J. W.
    Mendenhall, M. A.
    Nichols, S.
    Piotrowska, Z.
    Wozniak, A. J.
    Raponi, M.
    Karlovich, C. A.
    Jaw-Tsai, S.
    Isaacson, J.
    Despain, D.
    Matheny, S. L.
    Rolfe, L.
    Allen, A. R.
    Camidge, D. R.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (18): : 1700 - 1709
  • [8] Updated Analysis of NEJ009: Gefitinib-Alone Versus Gefitinib Plus Chemotherapy for Non-Small-Cell Lung Cancer With Mutated EGFR
    Miyauchi, Eisaku
    Morita, Satoshi
    Nakamura, Atsushi
    Hosomi, Yukio
    Watanabe, Kana
    Ikeda, Satoshi
    Seike, Masahiro
    Fujita, Yuka
    Minato, Koichi
    Ko, Ryo
    Harada, Toshiyuki
    Hagiwara, Koichi
    Kobayashi, Kunihiko
    Nukiwa, Toshihiro
    Inoue, Akira
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (31) : 3587 - +
  • [9] Cost-effectiveness analysis of afatinib vs gefitinib in EGFR-Mutated population with advanced non-small-cell lung cancer
    Chouaid, Christos
    De Pouvourville, Gerard
    Laura, Luciani
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [10] Adjuvant Osimertinib in EGFR-Mutated Non-Small-Cell Lung Cancer
    Planchard, David
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (18): : 1780 - 1782
12345